|
|
.
See Category: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
ICD-10 (CM) Code and Descriptor
|
D66 |
Hereditary factor VIII deficiency
|
D66 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 41.51%
|
18.25%
|
11.53%
|
7.79%
|
5.68%
|
4.49%
|
3.18%
|
2.29%
|
1.77%
|
0.95%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D66*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96374
|
THER/PROPH/DIAG INJ IV PUSH |
1,271
|
1,271
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,043
|
1,048
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,020
|
1,023
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,013
|
1,020
|
|
J7192
|
FACTOR VIII RECOMBINANT NOS |
842
|
6,803,156
|
|
80053
|
COMPREHEN METABOLIC PANEL |
729
|
729
|
|
85240
|
CLOT FACTOR VIII AHG 1 STAGE |
728
|
772
|
|
J7207
|
FACTOR VIII PEGYLATED RECOMB |
636
|
2,211,925
|
|
J7205
|
FACTOR VIII FC FUSION RECOMB |
497
|
2,337,808
|
|
85610
|
PROTHROMBIN TIME |
474
|
480
|
|
J7209
|
FACTOR VIII NUWIQ RECOMB 1IU |
454
|
1,195,332
|
|
85730
|
THROMBOPLASTIN TIME PARTIAL |
371
|
387
|
|
J7170
|
INJ., EMICIZUMAB-KXWH 0.5 MG |
328
|
275,266
|
|
85335
|
FACTOR INHIBITOR TEST |
288
|
294
|
|
82728
|
ASSAY OF FERRITIN |
199
|
199
|
|
J7185
|
XYNTHA INJ |
196
|
370,376
|
|
J7183
|
WILATE INJECTION |
161
|
1,374,800
|
|
83540
|
ASSAY OF IRON |
151
|
151
|
|
J7204
|
INJ RECOMBIN ESPEROCT PER IU |
138
|
1,139,672
|
|
85027
|
COMPLETE CBC AUTOMATED |
133
|
137
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D66 related to the following DRG Codes:
813
|
